Everolimus tablets for patients with subependymal giant cell astrocytoma

Scott G Turner Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Surgery, Box 3624, Durham, NC 27710, USA+1 919 668 2650; +1 919 684 6674; [email protected]

, MD,

Katherine B Peters Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Medicine, Box 3624, Durham, NC 27710, USA

, MD PhD,

James J Vredenburgh Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Medicine, Box 3624, Durham, NC 27710, USA

, MD,

Annick Desjardins Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Medicine, Box 3624, Durham, NC 27710, USA

, MD,

Henry S Friedman Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Surgery, Box 3624, Durham, NC 27710, USA+1 919 668 2650; +1 919 684 6674; [email protected]; Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Pediatrics, Box 3624, Durham, NC 27710, USA

, MD &

David A Reardon Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Surgery, Box 3624, Durham, NC 27710, USA+1 919 668 2650; +1 919 684 6674; [email protected]; Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Pediatrics, Box 3624, Durham, NC 27710, USA

, MD

Everolimus tablets for patients with subependymal giant cell astrocytoma

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Everolimus tablets for patients with subependymal giant cell astrocytoma

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date